Leadership & Professional Development

Initiative to Standardize a Clinical Trial Educational Program

Karen A. Stepan

Amy P. Gonzalez

Nita D. Pyle

Louise A. Villejo

Scott B. Cantor

clinical trials, standards, cancer program development/evaluation
ONF 2010, 37(5), 535-539. DOI: 10.1188/10.ONF.535-539

Jump to a section


    Avis, N. E., Smith, K. W., Link, C. L., Hortobagyi, G. N., & Rivera, E. (2006). Factors associated with participation in breast cancer treatment clinical trials. Journal of Clinical Oncology, 24, 1860-1867. doi: 10.1200/JCO.2005.03.8976
    Barrett, R. (2005). Quality of informed consent: Measuring understanding among participants in oncology clinical trials. Oncology Nursing Forum, 32, 751-755. doi: 10.1188/04.ONF.743-750
    Beskow, L. M., Sandler, R. S., Millikan, R. C., & Weinberger, M. (2005). Patient perspectives on research recruitment through cancer registries. Cancer Causes and Control, 16, 1171-1175. doi: 10.1007/s10552-005-0407-2
    Cox, K. (2002). Informed consent and decision making: Patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials. Patient Education and Counseling, 46, 31-38.
    Cox, K., & McGarry, J. (2003). Why patients don't take part in cancer clinical trials: An overview of the literature. European Journal of Cancer Care, 12, 114-122. doi: 10.1046/j.1365-2354.2003.00396.x
    Ellis, P. M., Butow, P. N., Tattersall, M. H., Dunn, S. M., & Houssami, N. (2001). Randomized clinical trials in oncology: Understanding and attitudes predict willingness to participate. Journal of Clinical Oncology, 19, 3554-3561. Retrieved from http://jco.ascopubs.org/cgi/content/full/19/15/3554 http://jco.ascopubs.org/cgi/content/full/19/15/3554
    Ellis, P. M., Butow, P. N., & Tattersall, M. H. N. (2002). Informing breast cancer patients about clinical trials: A randomized clinical trial of an educational booklet. Annals of Oncology, 13, 1414-1423. Retrieved from http://annonc.oxfordjournals.org/content/13/9/1414.long http://annonc.oxfordjournals.org/content/13/9/1414.long
    Hutchison, C., & Campbell, S. (2002). Evaluation of an information booklet for patients considering participation in phase I clinical trials in cancer. European Journal of Cancer Care, 11, 131-138. doi: 10.1046/j.1365-2354.2002.00308.x
    Kornblith, A. B., Kemeny, M., Peterson, B. L., Wheeler, J., Crawford, J., Bartlett, N., … Cohen, H. J. (2002). Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer, 95, 989-996. doi: 10.1002/cncr.10792
    McTiernan, A. (2003). Issues surrounding the participation of adolescents with cancer in clinical trials in the UK. European Journal of Cancer Care, 12, 233-239. doi: 10.1046/j.1365-2354.2003.00406.x
    Menikoff, J. (2005). Full disclosure: Telling patients when not being a research subject is a good choice. Perspectives in Biology and Medicine, 48(1, Suppl.), S139-S149. doi: 10.1353/pbm.2005.0025
    Oppenheim, D., Geoerger, B., & Hartmann, O. (2005). Ethical issues in pediatric oncology phase I-II trials based on a mother's point of view. Bulletin du Cancer, 92(11), E57-E60.
    Stevens, T., & Ahmedzai, S. H. (2004). Why do breast cancer patients decline entry into randomised trials and how do they feel about their decision later: A prospective, longitudinal, in-depth interview study. Patient Education and Counseling, 52, 341-348. doi: 10.1016/S0738-3991(03)00041-7
    Weinfurt, K. P., Depuy, V., Castel, L. D., Sulmasy, D. P., Schulman, K. A., & Meropol, N. J. (2005). Understanding of an aggregate probability statement by patients who are offered participation in phase I clinical trials. Cancer, 103, 140-147. doi: 10.1002/cncr.20730
    Wright, J. R., Whelan, T. J., Schiff, S., Dubois, S., Crooks, D., Haines, P. T., … Levine, M. N. (2004). Why cancer patients enter randomized clinical trials: Exploring the factors that influence their decision. Journal of Clinical Oncology, 22, 4312-4318. doi: 10.1200/JCO.2004.01.187